Reducing Postoperative Opioids in Patients Undergoing Laparoscopic Hiatal Hernia

Launched by ENDEAVOR HEALTH · Jul 17, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at ways to reduce the use of opioids (strong pain medications) for patients undergoing laparoscopic hiatal hernia repair surgery. The study will involve 75 participants who are randomly assigned to one of two groups: one will receive anesthesia that minimizes opioid use, while the other group will receive standard opioid-based anesthesia. Researchers want to see if the group using less opioids experiences less pain and fewer side effects after surgery, such as nausea or the need for extra care after leaving the hospital.

To join the study, participants must be between 18 and 90 years old and scheduled for elective laparoscopic hiatal hernia surgery. Those who are having emergency surgery or have certain allergies to the medications used in the trial will not be eligible. If you participate, you will be monitored for pain levels, medication use, and any complications during your hospital stay. Overall, this study aims to improve recovery experiences for patients by finding safer ways to manage pain after surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients from 18-90 years old who are undergoing laparoscopic hiatal hernia surgery
• • Elective Laparoscopic hiatal hernia repair
• Exclusion Criteria:
• • Patients receiving urgent or emergent hiatal hernia surgery
• • Patients receiving hiatal hernia surgery without laparoscopy
• • Patients with adverse reactions (e.g., anaphylaxis, rash) to any of the drugs in the OBA or OSA protocols.